Showing results (1-10 of 214) with videos related to
Sort By:
Pageof 22
Expert Opinion on Therapeutic Targets|November 14, 2015
Casein kinases as potential therapeutic targetsGiorgio Cozza, Lorenzo A PinnaExpert Opinion on Therapeutic Patents|August 23, 2012
Protein kinase CK2 inhibitors: a patent reviewGiorgio Cozza, Lorenzo A Pinna, Stefano MoroBiomed Research International|November 12, 2015
The Selectivity of CK2 Inhibitor Quinalizarin: A ReevaluationGiorgio Cozza, Andrea Venerando, Stefania Sarno, et al.The FEBS Journal|February 26, 2017
Fam20C is under the control of sphingolipid signaling in human cell linesGiorgio Cozza, Mauro Salvi, Vincent S Tagliabracci, et al.Plos One|March 4, 2014
Synthesis and properties of a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2)Giorgio Cozza, Sofia Zanin, Renate Determann, et al.Plos One|March 2, 2018
The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131Jordi Vilardell, Cristina Girardi, Oriano Marin, et al.Bioorganic & Medicinal Chemistry|September 15, 2009
Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2Alessandra Gianoncelli, Giorgio Cozza, Andrzej Orzeszko, et al.Molecular and Cellular Biochemistry|December 13, 2005
Autophosphorylation at the regulatory beta subunit reflects the supramolecular organization of protein kinase CK2Mario A Pagano, Stefania Sarno, Giorgia Poletto, et al.Biochimica Et Biophysica Acta|May 5, 2015
Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effectsSofia Zanin, Michele Sandre, Giorgio Cozza, et al.Biochimica Et Biophysica Acta|May 5, 2015
A new role for sphingosine: Up-regulation of Fam20C, the genuine casein kinase that phosphorylates secreted proteinsGiorgio Cozza, Mauro Salvi, Sourav Banerjee, et al.Pageof 22